Status:
COMPLETED
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
Lead Sponsor:
University Hospital, Akershus
Collaborating Sponsors:
Solvay Pharmaceuticals
Conditions:
Parkinson Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
An open, observational health economic study to estimate marginal cost and health consequences of replacing conventional Parkinsons disease therapy with intraduodenal levodopa administered continuousl...
Eligibility Criteria
Inclusion
- Clinical diagnosis of of idiopathic Parkinsons disease
- Motor fluctuations despite optimised per oral treatment
Exclusion
- Severe dementia, confusion, psychosis or depression
- Patients with contraindications against levodopa treatment
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00272688
Start Date
January 1 2006
End Date
May 1 2009
Last Update
December 30 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Akershus University Hospital
Nordbyhagen, Norway, 1474
2
Dept Neurology, Ulleval University Hospital
Oslo, Norway, 0450